0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,750USDGBP
From
EUR$2,699USDGBP
Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
EUR$2,699USDGBP
Hepatitis D Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hepatitis D Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
EUR$2,699USDGBP
Liver Fibrosis Market - Product Thumbnail Image

Liver Fibrosis Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
EUR$4,999USDGBP
Hepatic Disease Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hepatic Disease Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
EUR$4,949USDGBP
Kidney Stone Management Market Report and Forecast 2024-2032 - Product Thumbnail Image

Kidney Stone Management Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
EUR$4,949USDGBP
Calciphylaxis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Calciphylaxis Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
EUR$4,949USDGBP
Acute Pyelonephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Pyelonephritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$7,950USDGBP
Diabetic Nephropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Nephropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Chronic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
EUR$3,000USDGBP
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Alport Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Alport Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Acute Kidney Injury- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Kidney Injury- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Alcoholic Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Alcoholic Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more